Escalation Treatment with Methylprednisolone Versus Immunoadsorption in MS Relapse: Results of the EMMA Trial (P11-1.011)
To demonstrate superior efficacy of immunoadsorption (IA) over double-dose intravenous methylprednisolone (dd-IVMP) as escalated relapse treatment in multiple sclerosis (MS).
Authors
- Achim Berthele (ORCID: https://orcid.org/0000-0001-9650-6222)
- Clemens Goedel
- Annegret Franke
- Clemens Warnke (ORCID: https://orcid.org/0000-0002-3510-9255)
- Florian Then Bergh (ORCID: https://orcid.org/0000-0001-8604-8408)
- M Spaeth
- Claudius Kuechle
- Muriel Stoppe
- Nicole Koeppe-Bauernfeind
Institutions
- University of Cologne (DE)
- TUM Klinikum (DE)
- Klinik und Poliklinik für Neurologie (DE)
- Neurology, Inc (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211924
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00